1. Dipòsit Digital de la Universitat de Barcelona
  2. Recerca
  3. IDIBAPS: Institut d'investigacions Biomèdiques August Pi i Sunyer
  4. Articles publicats en revistes (IDIBAPS: Institut d'investigacions Biomèdiques August Pi i Sunyer)
Please use this identifier to cite or link to this item: http://hdl.handle.net/2445/203780
Full metadata record
DC FieldValueLanguage
dc.contributor.authorDíaz González, Álvaro-
dc.contributor.authorHernández Guerra, Manuel-
dc.contributor.authorPérez Medrano, Indhira-
dc.contributor.authorSapena, Víctor-
dc.contributor.authorRiveiro Barciela, Mar-
dc.contributor.authorBarreira Díaz, Ana-
dc.contributor.authorGómez, Elena-
dc.contributor.authorMorillas, Rosa M.-
dc.contributor.authorBarrio, María del-
dc.contributor.authorEscudé, Laia-
dc.contributor.authorMateos, Beatriz-
dc.contributor.authorHorta, Diana-
dc.contributor.authorGómez, Judith-
dc.contributor.authorConde, Isabel-
dc.contributor.authorFerre Aracil, Carlos-
dc.contributor.authorEl Hajra, Ismael-
dc.contributor.authorArencibía, Ana-
dc.contributor.authorZamora, Javier-
dc.contributor.authorFernández, Ainhoa-
dc.contributor.authorSalcedo, Magdalena-
dc.contributor.authorMolina, Esther-
dc.contributor.authorSoria, Anna-
dc.contributor.authorEstévez, Pamela-
dc.contributor.authorLópez, Carmen-
dc.contributor.authorÁlvarez Navascúes, Carmen-
dc.date.accessioned2023-11-17T12:17:48Z-
dc.date.issued2023-04-01-
dc.identifier.issn1527-3350-
dc.identifier.urihttp://hdl.handle.net/2445/203780-
dc.description.abstractIn patients with non-severe acute or chronic autoimmune hepatitis (AIH) without cirrhosis, clinical practice guidelines recommend indistinct use of prednisone or budesonide. However, budesonide is infrequently used in clinical practice. We aimed to describe its use and compare its efficacy and safety with prednisone as first-line options.ca
dc.format.extent39 p.-
dc.format.mimetypeapplication/pdf-
dc.language.isoengca
dc.publisherWolters Kluwer Healthca
dc.relation.isformatofVersió postprint del document publicat a: https://doi.org/10.1097/hep.0000000000000018-
dc.relation.ispartofHepatology, 2023, vol. 77, num. 4, p 1095-1105-
dc.relation.urihttps://doi.org/10.1097/hep.0000000000000018-
dc.rights(c) American Association for the Study of Liver Diseases, 2023-
dc.sourceArticles publicats en revistes (IDIBAPS: Institut d'investigacions Biomèdiques August Pi i Sunyer)-
dc.subject.classificationHepatitis-
dc.subject.classificationMalalties autoimmunitàries-
dc.subject.otherHepatitis-
dc.subject.otherAutoimmune diseases-
dc.titleBudesonide as first-line treatment in patients with autoimmune hepatitis seems inferior to standard predniso(lo)ne administrationca
dc.typeinfo:eu-repo/semantics/articleca
dc.typeinfo:eu-repo/semantics/acceptedVersion-
dc.rights.accessRightsinfo:eu-repo/semantics/openAccessca
dc.identifier.pmid36626622-
Appears in Collections:Articles publicats en revistes (IDIBAPS: Institut d'investigacions Biomèdiques August Pi i Sunyer)

Files in This Item:
File Description SizeFormat 
HEP-22-0918.R2_Proof_hi.pdf1.12 MBAdobe PDFView/Open
Show simple item record


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.